Asked by
Georges Oubary
on Dec 09, 2024Verified
A person with Alzheimer's disease is taking a drug designed to affect acetylcholine and glutamate and may experience:
A) improvement in short-term memory but not in ability to cope under pressure.
B) improvement in ability to cope under pressure but not in short-term memory.
C) improvement both in short-term memory and in ability to cope under pressure.
D) neither improvement in short-term memory, nor in ability to cope under pressure.
Acetylcholine
A neurotransmitter in the nervous system involved in many functions including muscle contraction and memory formation.
Glutamate
A major excitatory neurotransmitter in the brain, involved in learning, memory, and neural communication.
- Comprehend the constraints and efficacy of existing treatments for Alzheimer's disease.
Verified Answer
BL
Learning Objectives
- Comprehend the constraints and efficacy of existing treatments for Alzheimer's disease.
Related questions
Which Statement BEST Describes the Limitations of the Current Treatment ...
Which Statement Regarding the Use of Drug Therapy to Slow ...
Which Has NOT Been Used as a Cognitive-Behavioral Treatment for ...
Which of the Following Statements About Treatment of Alzheimer Disease ...
Which Is an Example of a Sociocultural Approach to Treating ...